Evidence-based programs for skin rejuvenation, hair restoration, collagen support, and regenerative aesthetics — grounded in clinical science.
Aesthetic Medicine
Evidence-based programs for skin rejuvenation, hair restoration, collagen support, and regenerative aesthetics — grounded in clinical science.
This content is for educational purposes only. It does not replace consultation with a licensed clinician and does not constitute medical advice. All aesthetic and medical treatment decisions require individual clinical evaluation and physician oversight. Results vary by patient. Do not self-administer any medication, compound, or treatment based on this article.
Aesthetic Medicine: Evidence-Based Programs for Skin, Hair, and Tissue Health
Aesthetic medicine at Advanced Vitality Group applies clinical science to the preservation and restoration of skin structure, hair follicle health, collagen integrity, and tissue quality. Every program we offer is grounded in peer-reviewed clinical evidence, and we are transparent about the hierarchy of that evidence — from FDA-approved interventions with multiple randomized controlled trials to emerging therapies where human data is still accumulating.
The visible signs of skin and hair aging are not merely cosmetic — they reflect measurable biological processes. Dermal collagen content declines at approximately 1% per year after age 20 (Varani J et al., American Journal of Pathology, 2006). Women lose approximately 30% of dermal collagen in the first five years after menopause due to estrogen decline (Brincat M et al., BJOG, 1985). In men, androgenetic alopecia affects approximately 50% by age 50, driven by DHT-mediated follicular miniaturization. These are biological processes — many of them modifiable — not simply inevitable consequences of time.
Key Takeaways
Dermal collagen declines ~1% per year after age 20 — a measurable, partially modifiable biological process.
Daily broad-spectrum SPF 30+ has the strongest evidence of any anti-aging skin intervention (Grade A RCT evidence).
FDA-approved treatments for androgenetic alopecia include topical minoxidil and oral finasteride — both with large RCT databases.
Oral hydrolyzed collagen peptides (2.5–10 g/day) have demonstrated improvements in skin elasticity, hydration, and collagen density in multiple RCTs.
Hormonal status — estrogen, testosterone, thyroid hormones — directly influences skin thickness, collagen synthesis, and hair follicle cycling.
Regenerative approaches (PRP, growth factors) have growing evidence bases; their evidence levels differ by application and require transparent disclosure.
What Aesthetic Medicine Actually Addresses
The aesthetic concerns we address at Advanced Vitality Group fall into four primary biological categories, each with its own evidence base and treatment framework:
1. Skin Aging and Photoaging
Skin aging results from two overlapping processes. Intrinsic aging — driven by cellular senescence, declining fibroblast activity, collagen loss, and reduced hyaluronic acid synthesis — affects all individuals regardless of environmental exposure. Extrinsic aging — primarily photoaging from cumulative UV radiation — is superimposed on intrinsic aging and dramatically accelerates it. UV radiation activates matrix metalloproteinases (MMPs) that degrade existing collagen and elastin, induces oxidative DNA damage in keratinocytes and fibroblasts, and produces chronic low-grade inflammation that further impairs skin repair.
The clinical result is a spectrum from fine surface lines (from intrinsic aging and dehydration) to deeper rhytids, lentigines, telangiectasias, and significant loss of skin volume and elasticity (from combined intrinsic and extrinsic aging). The most evidence-supported interventions — daily SPF, prescription tretinoin, and collagen peptide supplementation — address this biology directly and are the foundation of our skin programs.
2. Hair Loss
Androgenetic alopecia (AGA) — male and female pattern hair loss — is the most prevalent cause of hair thinning and loss. In men, it follows a characteristic frontotemporal and vertex pattern driven by DHT-mediated miniaturization of genetically susceptible follicles. In women, the pattern is diffuse thinning across the crown. Both forms have FDA-approved pharmacological treatments. Secondary hair loss — from iron deficiency, thyroid dysfunction, vitamin D deficiency, or nutritional inadequacy — is identified through laboratory testing and addressed through targeted correction. Our hair restoration programs begin with an accurate diagnosis.
3. Collagen and Connective Tissue Health
Collagen is the structural backbone of skin, tendons, ligaments, bone, and blood vessels. Its progressive decline with age — accelerated by UV exposure, smoking, hormonal changes, and nutritional deficiencies — affects not just appearance but function: skin thickness, wound healing, joint integrity, and tendon resilience. Our collagen support programs address the biological determinants of collagen synthesis through nutrition (hydrolyzed collagen peptides, vitamin C), lifestyle modification, and hormonal optimization where clinically indicated.
4. Regenerative Aesthetics
Regenerative aesthetic approaches — including platelet-rich plasma (PRP), growth factor serums, and emerging cellular therapies — use the body's own repair mechanisms to improve skin quality, texture, and hair follicle function. These represent a rapidly evolving category with a growing but variable evidence base. PRP for androgenetic alopecia, for example, has multiple positive randomized controlled trials; exosome therapy, by contrast, remains investigational with no FDA-approved products. We present each intervention with its actual evidence level.
The Hormonal Foundation of Aesthetic Health
Hormonal status is one of the most clinically significant but under-recognized determinants of skin and hair health. Three hormonal systems are particularly relevant:
Estrogen
Stimulates fibroblast collagen synthesis, maintains dermal hydration through hyaluronic acid upregulation, and regulates sebaceous gland function. Post-menopausal estrogen decline produces measurable reductions in skin thickness and collagen density within years. The Nurses' Health Study and multiple clinical trials have documented the skin-collagen-preserving effects of hormone therapy in post-menopausal women.
Testosterone and DHT
Testosterone in men contributes to skin sebum production and thickness; DHT (via 5α-reductase conversion) drives androgenetic alopecia in genetically susceptible individuals. In men with confirmed testosterone deficiency, hypogonadism is associated with skin thinning and impaired wound healing — effects that may partially reverse with appropriate TRT.
Thyroid hormones
Both hypothyroidism and hyperthyroidism produce distinct patterns of skin and hair changes. Hypothyroidism — even subclinical — causes dry, rough skin, diffuse hair thinning, loss of outer eyebrow hair, and impaired keratinocyte proliferation. Free T3, the metabolically active thyroid hormone, is evaluated as part of our aesthetic workup in patients with these features.
At Advanced Vitality Group, aesthetic programs are coordinated with hormonal evaluation where clinically indicated. Hormonal therapy is not initiated for cosmetic purposes alone — it requires clinical indication per established guidelines — but correcting documented deficiency addresses one of the most impactful modifiable factors in skin and hair health.
Foundational Evidence Hierarchy in Aesthetic Medicine
| Intervention | Evidence Level | Key Finding | Notes |
|---|---|---|---|
| Daily SPF 30+ (broad-spectrum) | Grade A — RCT | No detectable increase in skin aging scores over 4 years in daily users vs. as-needed (Hughes MCB et al., Annals of Internal Medicine, 2013) | Strongest evidence of any aesthetic anti-aging intervention |
| Topical tretinoin (0.025–0.1%) | Grade A — multiple RCTs | Significantly reduces fine lines, improves skin texture, stimulates collagen, reverses photoaging (Weiss JS et al., JAMA, 1988; multiple confirmatory trials) | Prescription required; titrate slowly |
| Topical minoxidil 5% (AGA) | Grade A — FDA-approved | Significantly greater hair regrowth than 2% and placebo at 48 weeks (Olsen EA et al., JAAD, 2002) | Continuous use required |
| Finasteride 1 mg/day (male AGA) | Grade A — FDA-approved | 83% of men maintained or improved hair count at 2 years vs. placebo (FPHL Study Group, JAAD, 1998) | Prescription required; discuss risk profile |
| Oral hydrolyzed collagen (2.5–10 g/day) | Grade B — multiple RCTs, meta-analysis | Significant improvements in skin elasticity, hydration, and collagen density across 19 studies (Barati M et al., JDD, 2020) | Combine with vitamin C for enhanced synthesis |
| PRP for androgenetic alopecia | Grade B — multiple RCTs | Significant improvements in hair density and shaft diameter vs. placebo (systematic review, Gupta AK, 2019) | Protocol variability; autologous; not FDA-approved for this indication |
What This Approach Is Not
To be clear about what we do and do not offer:
Not aggressive cosmetic marketing. We do not promise results we cannot support with published clinical data, and we do not describe interventions with greater certainty than the evidence warrants.
Not a replacement for foundational habits. Sun protection, adequate nutrition, sleep, smoking cessation, and stress management have powerful effects on skin and hair health that no clinical intervention fully substitutes for.
Not unsupervised hormone or peptide use for cosmetic goals. Every intervention requires physician evaluation and clinical indication confirmed by appropriate assessment.
Not a replacement for dermatology. Patients with active inflammatory skin disease, pigmented lesions requiring assessment, or suspected skin cancer are referred to dermatology for evaluation before or alongside aesthetic programs.
Our Aesthetic Programs at a Glance
Skin Rejuvenation
Photoprotection, tretinoin, topical vitamin C, laser treatments, and collagen nutrition for skin texture, tone, and structural integrity
Learn moreHair Restoration
Medical evaluation and treatment of androgenetic alopecia and secondary hair loss using FDA-approved options and evidence-based emerging therapies
Learn moreCollagen Support
Nutritional, hormonal, and supplemental approaches to collagen synthesis and preservation across skin, joints, and connective tissue
Learn moreRegenerative Aesthetics
PRP, growth factor applications, and emerging cellular approaches — presented with accurate evidence-level disclosure
Learn moreFrequently Asked Questions
Scientific References
- Varani J, et al. “Decreased collagen production in chronologically aged skin.” American Journal of Pathology. 2006;168(6):1861–1868.
- Hughes MCB, et al. “Sunscreen and prevention of skin aging.” Annals of Internal Medicine. 2013;158(11):781–790.
- Weiss JS, et al. “Topical tretinoin improves photoaged skin.” JAMA. 1988;259(4):527–532.
- Stevenson S, Thornton J. “Effect of estrogens on skin aging.” Clinical Interventions in Aging. 2007;2(3):283–297.
- Barati M, et al. “Collagen supplementation for skin health: a mechanistic systematic review.” Journal of Drugs in Dermatology. 2020;19(9):890–895.
- Brincat M, et al. “Long-term effects of the menopause and sex hormones on skin thickness.” BJOG. 1985;92(3):256–259.
Begin Your Aesthetic Program
Schedule a consultation to discuss your aesthetic goals with our physician-supervised team.